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1. Introduction 
The rare “Bombay” 0, blood group phenotype is 
characterised by the absence of A, B or H substances 
from the erythrocytes or secretions and the presence 
of anti-A, B and H agglutinins in the plasma [l] . In- 
dividuals belonging to this group were predicted to be 
of the genotype hh [ 2,3] and thus to lack the H-ac- 
tive structures that are formed by the enzymic pro- 
duct of the H-gene, the common allele at this genetic 
locus. H-active structures are the acceptor substrate 
for the A-gene specified a-Nacetylgalactosaminyl- 
transferase and the B-gene specified a-D-galactosyl- 
transferase [4-71 ; the lack of A- and B-specific struc- 
tures in the “Bombay” 0, individuals can thus be ex- 
plained by the absence of the H-gene product and it is 
unnecessary to assume a defect in, or failure of expres- 
sion of, the enzymic products of the A and B genes. 
In normal blood group A and B individuals the trans- 
ferases associated with the A and B genes have recent- 
ly been demonstrated in serum or plasma [ 8- 111. 
Therefore, to test the hypothesis that these genes are 
expressed normally at the enzymic level in “Bombay” 
0, individuals, serum or plasma from nine donors of 
this phenotype were examined for a-N-acetylgalactos- 
aminyl- and a-D-galactosyl-transferases. Whenever pos- 
sible, the findings on the sera were correlated with 
family data which enabled the probable ABO geno- 
type of the 0, donors to be deduced. The results dem- 
onstrated that the enzymes are readily detectable in 
the sera from the “Bombay” Oh donors and that the 
assay of these serum transferases provides a method 
for establishing whether A and B genes are carried by 
donors of this phenotype. 
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2. Materials and methods 
Unlabelled uridine diphosphate D-galactose (UDP- 
galactose) was purchased from Sigma London Chem- 
ical Company Ltd. and UDP-[14C] galactose (240 
mCi/mmole) from the Radiochemical Centre, Amer- 
sham, England. Unlabelled uridine diphosphate N-ace- 
tyl-D-galactosamine (UDP-N-acetylgalactosamine) was 
prepared by the method of Carlson et al. [ 121 and 
UDP-N-acetyl-[ 14C] galactosamine (43 mCi/mmole) 
was purchased from the New England Nuclear Corp- 
oration, Frankfurt, Germany. 2’-Fucosyllactose (@a- 
L-fucosyl-( 1+2)-O-P-D-galactosyl (1+4)-D-glucose) 
was supplied by Dr. A. Gauhe. 
Paper chromatography was carried out in ethyl ace- 
tate-pyridine-water (2: 1: 2 by vol, upper phase; sol- 
vent a) on Whatman No 40 paper. Radioactive peaks 
were detected with a 7201 Packard Radiochromato- 
gram Scanner and counted in a Nuclear Chicago Scin- 
tillation counter, Series 720. 
Serum samples from the “Bombay” Oh donors S.A., 
GOV. and SOO. (see table 1) were provided by Miss 
Phyllis Moores of the Natal Blood Transfusion Service, 
South Africa, who also supplied the following details: 
Both parents of S.A. were group 0 and therefore her 
genotype is 00. GOV. and SOO. are brothers whose 
parents were group 0 and A,B. The brothers both 
have group B wives; GOV. has one group B child and 
SOO. has one group 0 child and five group B children. 
Serum from the donor V.D’A. was supplied by Dr. R. 
Sacchi, Centro Transfusionale Bologna, Italy. The fam- 
ily pedigree of this donor [ 131 demonstrates that V. 
D’A’s genotype must be A20 or 00. Serum samples 
from three donors, P.D., M.S. and SUB. were provided 
by Dr. H.M. Bhatia, Blood Group Reference Centre, 
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Table 1 
October 1972 
The a-N-acetyl-D-galactosaminyl- and a-D-galactosyltransferase activities in sera from nine “Bombay” Oh donors 
Serum 
donor 
S.A. 
G.F. 
V.D’A. 
P.D. 
M.S. 
SUB 
SCH 
GOV 
so0 
F.J. 
W.M. 
ABO group 
Phenotype Genotype* 
oh 00 
Oh Not known 
oh OOorAzO 
0, Not known 
0, Not known 
Oh AO, BO, AB 
or 00 
Oh 00 
Oh AtOor BQ 
oh AlOorBO 
AIB AIB 
0 00 
Radioactivity incorporated 
into 2’-fucosyllactose as: 
a[ “C]Gal a[‘4C]GalNAc 
%of % of 
cpm total cpm total 
0 0 0 0 
0 0 0 0 
0 0 13,184 6.5 
20,848 10 21,530 11 
19,124 9.5 0 0 
30,658 15 32,214 16 
0 0 0 0 
0 0 17,229 8.6 
16,247 8.1 0 0 
18,510 7.7 15,954 7.3 
0 0 0 0 
Predicted 
genotype 
00 
,420 
AB 
BO 
AB 
AlO 
BO 
* Deduced from family studies (see Materials and methods). 
Abbreviations: Gal, D-galactose; GalNAc, N-acetyl-D-galactosamine. 
Reaction mixture: 0.6-1.0 nmole UDP-[ “‘Cl galactose (200,000-240,000 cpm) or 3.3 nmole UDP-IV-acetyl-[ “‘Cjgalactosamine 
200,000 cpm); 2.0 bmole MnCla (except for mixture with plasma from donor SCH. which contained 4.0 pmole MnC12); 1.0 
pmole ATP; 0.5 pmole 2’-fucosyllactose; 7.0 pmole sodium cacodylate buffer, pH 6.5; 20 ~1 serum or plasma. Total volume of 
the reaction mixture 200 ~1. Incubated at 37” for 18 hr. 
Bombay, India. No family data was available on do- 
nor P.D.. Donor MS. had a group B parent, one group 
B sib and two group 0 children [ 141. Donor SUB’s 
parents were group A and B and data on his sibs indi- 
cate that the parents’ genotypes must be A0 and BO 
[ 141 . Citrated plasma from donor SCH. was sent by 
Dr. Ch. Salmon, Centre Departemental de Transfusion 
Sanguine, Paris, who gave the donor’s genotype as 00. 
No family data was available on donor G.F. whose serum 
was provided by Dr. B.P.L. Moore of the Canadian Red 
Cross Blood Transfusion Service, Toronto, Canada. 
Whole blood, serum or plasma was received from all 
these donors within two to three days after withdraw- 
al of the blood and the samples were transported un- 
der refrigeration. Separated serum or plasma that was 
not used on the day of arrival was stored at -18” and 
then used immediately after the sample had thawed 
out. 
The transferases in the sera were assayed by two 
methods. The first was the transfer of IV-acetyl- [“Cl 
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galactosamine or [ 14C] D-galactose from their respec- 
tive uridine derivatives to the low molecular weight 
acceptor, 2’-fucosyllactose. The reaction conditions 
are given in table 1. At the end of the incubation peri- 
od the neutral sugars were separated from the charged 
compounds as described previously [ 151 and chro- 
matographed in solvent a. The anomeric linkage of 
the transferred N-acetylgalactosamine was determined 
by treatment with an a-N-acetylgalactosaminidase 
from Lumbricus terrestris [ 161 that was free from fl- 
activity. The linkage of the transferred galactose was 
determined by treatment with purified Q! and /3-galac- 
tosidases from Trichomonas foe&s [ 17,181. 
The second method for the detection of the trans- 
ferases was conversion of normal group 0 cells to A- 
and/or B-active cells by the transfer of sugars from 
the unlabelled nucleotide derivatives [ 19,l l] . The 
sera from the “Bombay” Oh donors were absorbed 
with packed washed, group 0, A, and B red cells to 
remove the anti-H, -A and -B agglutinins. The reaction 
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Table 2 
Conversion of human group 0 cells to group A and B reactive cells by the transferases in sera from “Bombay” Oh donors. 
Serum 
donor 
ABO 
group 
Phenotype Genotype 
S.A. 
G.F. 
V.D’A. 
P.D. 
M.S. 
SUB 
SCH. 
GOV. 
so0 
E.S. 
W.W. 
W.M. 
Oh 
Oh 
Oh 
Oh 
Oh 
Oh 
Oh 
Oh 
Oh 
B 
Al 
00 
Not known 
OOorA20 
Not known 
Not known 
AO,BO,AB 
or 00 
00 
AlOorBO 
AlOorBO 
BB or BO 
Not known 
0 00 
Haemagglutination end-point after treatment of 
0 cells with serum and: 
UDP-Gal UDP-GaINAc 
Anti-A Anti-B Anti-A Anti-B 
<1:2 <1:2 <1:2 <1:2 
<1:2 <1:2 <I:2 <1:2 
<1:2 <1:2 1:4 <1:2 
<1:2 1:256 1:128 <1:2 
<1:2 1:128 <1:2 <1:2 
<1:2 1:256 1:256 <1:2 
<1:2 <1:2 <1:2 <1:2 
<1:2 <1:2 1:256 <1:2 
<1:2 1:128 <1:2 <1:2 
<1:2 1:256 <1:2 <1:2 
<1:2 <1:2 1:128 <1:2 
<1:2 <1:2 <1:2 <1:2 
Reactivity 
of 
converted 
cells 
Weak A 
AB 
B 
AB 
Reaction mixture: 100 fig UDP-galactose or UDP-N-acetylgalactosamine; 1 CtmoIe MnCl 2; 0.5 pmole ATP; 5 ~1 packed group 0 
erythrocytes; absorbed serum 50 ccl. Total volume of the reaction mixture 70 ~1. Incubated for 6 hrs. at 37”. 
mixture used for the cell conversion experiments is 
given in table 2. At the end of the incubation period 
the red cells were collected by centrifuging at 2,000 
rpm and washed twice with several volumes of 0.9% 
NaCl. A 1% suspension of the washed cells was tested 
for haemagglutination as described previously [ 201 . 
Human anti-A and anti-B sera were used as the test re- 
agents and the end-point of agglutination was taken 
as the last dilution of the serum at which clumps of 
two or three cells were visible under the low power of 
the microscope. 
3. Results 
Nine serum samples from “Bombay” 0, donors 
were each tested for cu-N-acetylgalactosaminyl and CY- 
galactosyl-transferase activity with 2’-fucosyllactose 
as acceptor (table 1). The sera from a normal A,B 
donor and a group 0 donor were included as controls. 
The AIB serum and four of the “Bombay” 0, sera 
(V.D’A., P.D., SUB. and GOV.) transferredN-acetyl- 
[14C] galactosamine to the trisaccharide to give a com- 
pound (Rlactose3 0.5 in solvent a) which correspon- 
ded in its chromatographic properties to the tetra- 
saccharide previously synthesized with 2’-fucosyllac- 
tose as acceptor when group A tissues were used as 
the enzyme source [ 51. The labelled N-acetylgalacto- 
samine was released by the cr-N-acetylgalactosamini- 
dase preparation; thus confirming that the sugar was 
transferred in o-linkage. 
When UDP- [ 14C] galactose was used as the sugar 
donor, the A,B serum, and four of the “Bombay” 
0, sera (P.D., M.S., SUB. and SOO.) had a-galactosyl- 
transferase activity. The product (Rlactose, 0.4 in 
solvent a) co-chromatographed with the tetrasaccha- 
ride identified as O-a-D-galactosyl-( 1+3)- [O-a-L- 
fucosyl-( 1+2)-l 0/3-D-galactosyl-( 1+4)-D-glucose [21]. 
The radioactive galactose was cleaved from the tetra- 
saccharide by a-galactosidase and was not susceptible 
to the corresponding P-enzyme. Two of the “Bombay” 
0, donors, known to be of the genotype 00 (S.A. 
and SCH.), had neither ol_N-acetylgalactosaminyl nor 
Wgalactosyltransferase activity; serum from one Oh 
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Table 3 
The fl-galactosyltransferase activity in sera from “Bombay” 
Oh donors 
p[ 14C]Gal incorpo- 
Serum ABO rated into N- 
Donor phenotype acetylglucosamine 
cpm % 
S.A. Oh 155,422 76 
G.F. Oh 130,350 65 
V.D’A. Oh 147,436 74 
P.D. Oh 169,662 85 
M.S. Oh 148,782 71 
SUB. Oh 142,748 71 
SCH. Oh 211,068 100 
GOV. Oh 105,000 45 
so0 Oh 114,300 49 
E.S. B 156,346 78 
Reaction mixture: The same as in table 1 with UDP-[ 14C]ga- 
lactose as the sugar donor and with N-acetylglucosamine (0.5 
pmole) as the sugar acceptor in place of 2’-fucosyllactose. 
donor of unknown genotype was also devoid of these 
enzyme activities. The amount of radioactive sugar in- 
corporated into 2’-fucosyllactose under the conditions 
given in table 1 was not the maximum obtainable; in- 
creasing the time of incubation or the amount of se- 
rum in the reaction mixture resulted in greater incorp- 
oration. However, no cr-N-acetylgalactosaminyl or (II- 
galactosyltransferase activity was detectable in the 
samples S.A., G.F. and SCH. even after prolonged in- 
cubation with 50 ~1 of serum or plasma. In the 
“Bombay” On sera that had a-i\i-acetylgalactosaminyl 
and/or a-D-galactosyl transferases, the activities were 
retained largely unimpaired after storage of the sera 
for several months at - 18”. 
Absorption of the “Bombay” Oh sera with A, B 
and 0 erythrocytes to remove the agglutinins did not 
decrease the enzyme activities as measured by the 
transfer of labelled sugars to 2’-fucosyllactose. The ab- 
sorbed sera were therefore tested for their capacity to 
convert group 0 cells into A or B active cells in the 
presence of unlabelled UDP-N-acetylgalactosamine or 
UDP-galactose [ 19, 1 l] . Sera from the normal group 
ArB and 0 donors were included as controls. Four of 
the “Bombay” On sera (V.D’A., P.D., SUB. and GOV.) 
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converted the 0 cells into A active cells when UDP-N- 
acetylgalactosamine was included in the incubation 
mixture, although in one instance, (serum VD’A.) 
the treated cells were only weakly agglutinated by 
anti-A serum (table 2). More prolonged incubation of 
the group 0 cells with this particular serum sample 
did not increase the haemagglutination titre of cells 
with anti-A serum. With the other three Oh sera the 
degree of conversion to A was comparable with that 
given by the serum from a group Al donor. Similarly, 
the four Oh sera that transferred D-galactose to 2’- 
fucosyllactose (P.D., MS., SUB. and SOO.) convert- 
ed 0 cells to B-reactive cells when UDP-galactose was 
a component of the reaction mixture (table 2). The 
group 0 cells did not develop agglutinability with ei- 
ther anti-A or anti-B sera when incubated with the 
nucleotide sugars and the absorbed sera or plasma 
from the Oh donors S.A.. G.F. or SCH. 
Although cY-galactosyltransferase activity was de- 
monstrable in only certain of the “Bombay” Oh sam- 
ples, incubation of the sera with UDP-[ 14C] galactose 
and the monosaccharide N-acetylglucosamine reveal- 
ed strong P-galactosyltransferase activity in all the 
sera (table 3). A labelled disaccharide was formed that 
co-chromatographed with N-acetyllactosamine (O-/3- 
D-galactosyl-( 1+4)-N-acetylglucosamine) and was com- 
pletely hydrolysed by /3-galactosidase. 
4. Discussion 
The transfer of N-acetylgalactosamine from UDP- 
N-acetylgalactosamine and of D-galactose from UDP- 
galactose, in o-linkage to the H-active trisaccharide, 
2’-fucosyllactose, by transferases in certain “Bombay” 
Oh serum samples, demonstrates that enzymes with 
the specificity expected for the products of the A and 
B genes may, as predicted, be present in the sera of 
individuals of the “Bombay” On phenotype (table 1). 
Confirmatory evidence for the specificity of the trans- 
ferases was obtained by the conversion of group 0 
erythrocytes into A- or B-active cells by the correspon- 
ding sera in the presence of added nucleotide sugars 
(table 2). 
The ABO genotypes of only two of the nine “Bom- 
bay” On donors were known with certainty (S.A. and 
SCH.) and these were both homozygous 00. In agree- 
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ment with this genotype no a-N-acetylgalactosaminyl 
or a-D-galactosyltransferases were detectable in the 
serum from these donors, although both had strong /3- 
galactosyltransferase activity (table 3). The serum 
from one other donor (G.F.), for whom no family da- 
ta was available, behaved similarly in that only P-galac- 
tosyltransferase activity was demonstrable; it can 
therefore be predicted that the genotype of G.F. is 
00. 
Family studies on the relatives of the two brothers 
GOV. and SOO. indicate that their genotypes must be 
either A,0 or BO. The finding of an a-N-acetylgalacto- 
saminyltransferase in the serum GOV., with no trace 
of the B-gene specified enzyme, and of an cw-galacto- 
syltransferase in the serum SOO., in the absence of 
the A-gene specified enzyme, demonstrates that GOV. 
carries an A gene and is therefore of the genotype 
A,O, and that SOO. carries a B gene and is of the 
genotype BO. The donor V.D’A., whose genotype is 
known to be either 00 or A20 [ 131, had an a-N- 
acetylgalactosaminyltransferase and hence carries an 
A gene. With this serum the incorporation of N-acetyl- 
[‘“Cl galactosamine into the low molecular acceptor 
was more striking than the results obtained in the cell 
conversion experiments in which only weak A activity 
developed. The reason for this one discrepancy is not 
known although it may be attributable to the fact 
that the gene carried by this donor is A2 and not Al. 
The ABO blood groups of donor SUB.‘s family per- 
mit one to deduce only that his genotype is either AO, 
BO, AB or 00 [ 141. The demonstration of a strong 
a-N-acetylgalactosaminyl- and a-galactosyltransferase 
clearly indicates, however, that he is carrying both the 
A and B genes. Similarly, donor P.D., for whom no 
family data was available, had both the A- and B-gene 
specified transferases, and is thus of the genotype AB. 
Donor M.S. has a normal group 0 child and hence 
must be carrying an 0 gene [ 141. The blood groups 
of other members of the family indicate that he may 
be carrying a B gene but there is insufficient informa- 
tion for an unequivocal decision to be reached on this 
point. The presence of an cw-galactosyltransferase in 
his serum confirms, however, that his genotype is BO. 
In none of the nine “Bombay” Oh samples examin- 
ed were the ol-N-acetylgalactosaminyl- or a-galactosyl- 
transferases found in the serum at variance with those 
to be expected from the known family data. Provided 
that reasonably fresh serum samples are used, tests for 
the A- and B-gene specified transferases hould thus 
be a dependable method for ascertaining the true 
ABO group of donors of the “Bombay” Oh pheno- 
type. 
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